Khalid Al Jalham

Hamad Medical Corporation

Papers

1

Total Citations

2

H-Index

1

About

Dr. Khalid Al Jalham is a dedicated pathologist whose research centers on the diagnostic characterization of rare and emerging renal neoplasms. His most cited work, a 2024 case report on tubulocystic renal cell carcinoma (RCC), provides a critical clinical and histopathological description of this uncommon tumor—only recently recognized by the WHO as a distinct entity in 2016. By detailing the incidental diagnosis in a 35-year-old male and emphasizing its typically indolent behavior, Dr. Al Jalham contributes essential data to the sparse literature on this subtype, aiding pathologists in accurate identification and differentiation from more aggressive renal cancers. While his citation count is currently modest, his focused contribution to the understanding of tubulocystic RCC represents a valuable addition to the field of urological pathology. This work underscores his commitment to advancing knowledge of rare tumors, with the potential to inform clinical management and improve diagnostic precision for future cases.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Tubulocystic renal cell carcinoma: A case report of rare tumor
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Hamad Medical Corporation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago